316 related articles for article (PubMed ID: 26667209)
1. Epigenetic targets in cancer and aging: dietary and therapeutic interventions.
Khan S; Shukla S; Sinha S; Meeran SM
Expert Opin Ther Targets; 2016 Jun; 20(6):689-703. PubMed ID: 26667209
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.
Shukla S; Penta D; Mondal P; Meeran SM
Adv Exp Med Biol; 2019; 1152():293-310. PubMed ID: 31456191
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulators as therapeutic targets in prostate cancer.
Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
[TBL] [Abstract][Full Text] [Related]
4. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.
Shukla S; Meeran SM; Katiyar SK
Cancer Lett; 2014 Dec; 355(1):9-17. PubMed ID: 25236912
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
7. Promises and challenges of anticancer drugs that target the epigenome.
Verbrugge I; Johnstone RW; Bots M
Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic cancer therapy: rationales, targets and drugs.
Rius M; Lyko F
Oncogene; 2012 Sep; 31(39):4257-65. PubMed ID: 22179827
[TBL] [Abstract][Full Text] [Related]
11. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inhibitors.
Verma M; Banerjee HN
Methods Mol Biol; 2015; 1238():469-85. PubMed ID: 25421675
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic therapy for solid tumors: from bench science to clinical trials.
Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
[TBL] [Abstract][Full Text] [Related]
16. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
Mohammad HP; Barbash O; Creasy CL
Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions.
Jasek K; Kubatka P; Samec M; Liskova A; Smejkal K; Vybohova D; Bugos O; Biskupska-Bodova K; Bielik T; Zubor P; Danko J; Adamkov M; Kwon TK; Büsselberg D
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31323834
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic linkage of aging, cancer and nutrition.
Daniel M; Tollefsbol TO
J Exp Biol; 2015 Jan; 218(Pt 1):59-70. PubMed ID: 25568452
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
20. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
